Cite

HARVARD Citation

    Warf, M. et al. (2015). Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma. Biomarkers in medicine. pp. 901-910. [Online]. 
  
Back to record